Combined modality treatment for stage I-II non-Hodgkin's lymphomas: CVP versus BACOP chemotherapy.

[1]  W. Woods,et al.  The results of allogeneic bone marrow transplantation (BMT) in patients with acute non-lymphocytic leukemia (ANLL) in first remission: Comparison of two sequential studies utilizing different total body irradiation regimens , 1987 .

[2]  J. Connors,et al.  Brief chemotherapy and involved field radiation therapy for limited-stage, histologically aggressive lymphoma. , 1987, Annals of internal medicine.

[3]  M. van Glabbeke,et al.  EORTC trial non-Hodgkin lymphomas. , 1987, European journal of cancer & clinical oncology.

[4]  T. Speelman,et al.  Extranodal non-Hodgkin's lymphoma of the head and neck. , 1987, Radiotherapy and Oncology.

[5]  Flavio Crippa,et al.  Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy. , 1987, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  Jones Se.  Follicular lymphoma--do no harm. , 1986 .

[7]  G. Pinkus,et al.  Identification of major prognostic subgroups of patients with large-cell lymphoma treated with m-BACOD or M-BACOD. , 1986, Annals of internal medicine.

[8]  M. Kaminski,et al.  Factors predicting survival in adults with stage I and II large-cell lymphoma treated with primary radiation therapy. , 1986, Annals of internal medicine.

[9]  F. Berger,et al.  Intensive and sequential combination chemotherapy for aggressive malignant lymphomas (protocol LNH-80). , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  J. Ultmann,et al.  Treatment of diffuse histiocytic lymphoma (DHL) with COMLA (cyclophosphamide, oncovin, methotrexate, leucovorin, cytosine arabinoside): a 10-year experience in a single institution. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  E. Vokes,et al.  Long-term survival of patients with localized diffuse histiocytic lymphoma. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  D. Rosenthal,et al.  Improved survival following combined radiation therapy and chemotherapy for unfavorable prognosis stage I-II non-Hodgkin's lymphomas. , 1985, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Bonadonna,et al.  CVP versus BACOP Chemotherapy Sequentially Combined with Irradiation in Stage I–II Diffuse Non-Hodgkin’s Lymphomas , 1985 .

[14]  J. Connors,et al.  MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma. , 1985, Annals of internal medicine.

[15]  R. Hoppe.  The role of radiation therapy in the management of the non‐Hodgkin's lymphomas , 1985, Cancer.

[16]  C. Bloomfield,et al.  The role of radiation therapy in the treatment of early stage large cell lymphoma , 1985, Hematological oncology.

[17]  F. Cabanillas.  Chemotherapy as definitive treatment of stage I‐II large cell and diffuse mixed lymphomas , 1985, Hematological oncology.

[18]  N. Nissen,et al.  A randomized study of radiotherapy versus radiotherapy plus chemotherapy in stage I‐II non‐hodgkin's lymphomas , 2006, Cancer.

[19]  R S Cox,et al.  Extralymphatic involvement in diffuse non-Hodgkin's lymphoma. , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  T. Miller,et al.  Initial chemotherapy for clinically localized lymphomas of unfavorable histology. , 1983, Blood.

[21]  G. Bonadonna,et al.  Non-Hodgkin's Lymphomas of Waldeyer's Ring , 1983, Tumori.

[22]  R. Fisher,et al.  Diffuse aggressive lymphomas: increased survival after alternating flexible sequences of proMACE and MOPP chemotherapy. , 1983, Annals of internal medicine.

[23]  G. Pinkus,et al.  Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD). , 1983, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Pasmantier,et al.  Combination chemotherapy of advanced diffuse histiocytic lymphoma with the six-drug COP-BLAM regimen. , 1982, Annals of internal medicine.

[25]  M. Nerenberg,et al.  Randomized study comparing doxorubicin, cyclophosphamide, vincristine, methotrexate with leucovorin rescue, and cytarabine (ACOMLA) with cyclophosphamide, doxorubicin, vincristine, prednisone, and bleomycin (CHOP-B) in the treatment of diffuse histiocytic lymphoma. , 1982, Cancer treatment reports.

[26]  V. Rege,et al.  Malignant lymphoma of Waldeyer's ring following gastrointestinal lymphoma , 1980, Cancer.

[27]  G. Bonadonna,et al.  Improved five year survival after combined radiotherapy-chemotherapy for stage I-II non-Hodgkin's lymphoma. , 1980, International journal of radiation oncology, biology, physics.

[28]  L. Fuller,et al.  Laparotomy staged I and II non‐Hodgkin's lymphomas preliminary results of radiotherapy and adjunctive chemotherapy , 1980, Cancer.

[29]  R. Hoppe,et al.  Non‐Hodgkin's lymphoma. Involvement of Waldeyer's ring , 1978 .

[30]  M. Ross,et al.  Primary extranodal lymphoma. Response to treatment and factors influencing prognosis , 1978, Cancer.

[31]  G. Bonadonna,et al.  Sequential pathologic staging of untreated non‐Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy , 1977, Cancer.

[32]  M. Gospodarowicz,et al.  Radiation therapy of localized non-Hodgkin's lymphoma. , 1977, Cancer treatment reports.

[33]  R. Warnke,et al.  Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin's lymphomas. , 1977, Cancer treatment reports.

[34]  D. Rosenthal,et al.  The place of radiation therapy in the treatment of non‐Hodgkin's lymphomas , 1977, Cancer.

[35]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[36]  V. Devita,et al.  Bleomycin, adriamycin, cyclophosphamide, vincristine, and prednisone (BACOP) combination chemotherapy in the treatment of advanced diffuse histiocytic lymphoma. , 1976, Annals of internal medicine.

[37]  V. Devita,et al.  Sequential Nonsurgical and Surgical Staging of Non-Hodgkin's Lymphoma , 1976 .

[38]  B. H. Valentine.  Doctor in the Army , 1975 .

[39]  Z. Fuks,et al.  Patterns of presentation and relapse in the non-Hodgkin's lymphomata. , 1975, The British journal of cancer. Supplement.

[40]  L. Fuller,et al.  Extranodal non-Hodgkin's lymphomas of the head and neck. , 1975, The American journal of roentgenology, radium therapy, and nuclear medicine.

[41]  Z. Fuks,et al.  Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas. , 1973, Radiology.

[42]  G. Bonadonna,et al.  Malignant Lymphomas of Waldeyer's Ring: Natural History and Survival after Radiotherapy , 1972, British medical journal.

[43]  V. Devita,et al.  Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone. , 1972, Annals of internal medicine.

[44]  J. Berg,et al.  Occurrence and prognosis of extranodal lymphomas , 1972 .

[45]  H. Rappaport,et al.  Tumors of the hematopoietic system , 1966 .